Domenico Girelli: Continuing Commitment to Rare Disease Research
Domenico Girelli, Full Professor of Internal Medicine at the University of Verona, Director of the Department of Medicine at the University of Verona, and Director of the Internal and Emergency Unit at the University Hospital of Verona, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our commitment to research in rare diseases continues…”
Title: Dapagliflozin in Patients With CKD With Fabry Disease
Authors: Yuri Battaglia, Nicola Vitturi, Giacomo Marchi, Federica Baciga, Federica Caccia, Giorgia Gugelmo, Loris Martinetti, Lucia Federica Stefanelli, Sara Torresani, Antonio Pisani, Eleonora Riccio, Pasquale Esposito, Francesca Viazzi, Cristina Chimenti, Francesca Katiana Martino, Livia Lenzini, Annalisa Sechi, Luca Zanoli, Domenico Girelli, Gian Paolo Fadini, Gianni Carraro
Read the Full Article on Science Direct․
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?